Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Are there more tricks in the bag for treating thrombocytopenia?
Andrew D. Leavitt
Andrew D. Leavitt
Published October 25, 2010
Citation Information: J Clin Invest. 2010;120(11):3807-3810. https://doi.org/10.1172/JCI45179.
View: Text | PDF
Commentary

Are there more tricks in the bag for treating thrombocytopenia?

  • Text
  • PDF
Abstract

Thrombocytopenia, an abnormally low number of circulating platelets, results from inadequate platelet production, splenic platelet sequestration, or accelerated platelet clearance. Platelet transfusions are now the cornerstone for treating thrombocytopenia. With an ever-expanding demand for platelets, and with many patients having an inadequate response to platelet transfusions, new strategies are needed to treat thrombocytopenia. In this issue of the JCI, Fuentes et al. present provocative data regarding the use of direct megakaryocyte infusions as a novel approach to manage this vexing clinical problem.

Authors

Andrew D. Leavitt

×

Figure 1

Megakaryocytopoiesis and platelet production.

Options: View larger image (or click on image) Download as PowerPoint
Megakaryocytopoiesis and platelet production.
(A) A model for megakaryoc...
(A) A model for megakaryocytopoiesis demonstrates the progressive increase in size as megakaryocytes mature in the marrow, with mature megakaryocytes developing cytoplasmic projections called proplatelets. Platelet release occurs from the ends of proplatelet projections, with at least some platelet release occurring directly in the marrow circulation from proplatelet projections that extrude through the marrow’s fenestrated vasculature. (B) Fuentes et al. (19) have demonstrated that infused mature megakaryocytes release platelets into the circulation, thereby increasing circulating platelet counts, and that these platelets contribute to hemostasis at the site of vascular injury.
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts